Aspirin and prevention of stroke
- 22 January 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 343 (8891) , 233-235
- https://doi.org/10.1016/s0140-6736(94)91018-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.Circulation, 1993
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Antithrombotic Therapy in Atrial FibrillationChest, 1992
- Therapeutic target values in oral anticoagulation — Justification of Dutch policy and a warning against the so-called moderate-intensity regimensAnnals of Hematology, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- Preliminary Report of the Stroke Prevention in Atrial Fibrillation StudyNew England Journal of Medicine, 1990
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989